ProMIS Neurosciences (PMN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Promis Neurosciences chief scientific officer buys $14,595 in sharesFebruary 12, 2025 | msn.comProMIS Neurosciences initiates Phase 1b trial in Alzheimer’s diseaseJanuary 11, 2025 | markets.businessinsider.comProMIS Neurosciences stock hits 52-week low at $0.91November 22, 2024 | investing.comProMIS Neurosciences reports Q3 EPS 31c vs (19c) last yearNovember 15, 2024 | markets.businessinsider.comProMIS Neurosciences Presents Positive Data from PMN310 Phase1a Clinical Trial at the 17th Clinical Trials on Alzheimer’s Disease ConferenceOctober 30, 2024 | finance.yahoo.comProMIS Neurosciences, Inc. (PMN): Analysts Are Bullish On This Undervalued Canadian Stock NowOctober 13, 2024 | msn.comTargeting brain lesions with TMS shows promise in treating PTSD in veteransSeptember 27, 2024 | msn.comProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Second Quarter 2024 Financial Results and Recent HighlightsAugust 9, 2024 | finanznachrichten.deBuy Rating on ProMIS Neurosciences Backed by Innovative Alzheimer’s Treatment and Strong FinancialsAugust 9, 2024 | markets.businessinsider.comAnaergia: Top 10 Undervalued Growth Stocks on TSX (ANRG)July 27, 2024 | theglobeandmail.comPMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023April 1, 2024 | msn.comProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceFebruary 22, 2024 | finance.yahoo.comNerve stimulation plus physical rehabilitation may boost recovery of arm and hand functionFebruary 1, 2024 | msn.comProMIS Neurosciences Issues Letter to ShareholdersJanuary 8, 2024 | markets.businessinsider.comProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Publication on Novel Target for ALSDecember 20, 2023 | finanznachrichten.deProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNovember 20, 2023 | markets.businessinsider.comProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsNovember 14, 2023 | finance.yahoo.comProMIS Neurosciences Closes $20.4 Million Private Placement FinancingSeptember 8, 2023 | finance.yahoo.comProMIS Neurosciences Shares Jump on $20.4 Million Private PlacementAugust 22, 2023 | marketwatch.comProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsAugust 15, 2023 | finanznachrichten.deProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsAugust 14, 2023 | finance.yahoo.comPMN ProMIS Neurosciences, Inc.August 1, 2023 | seekingalpha.comToronto Stocks Edge Lower; ProMIS Neurosciences Soars on Positive Alzheimer's Treatment DataJuly 17, 2023 | marketwatch.comAlzheimer’s Drug Data Sends ProMIS Vaulting UpJuly 17, 2023 | msn.comWhy ProMIS Neurosciences Stock Surged TodayJuly 17, 2023 | msn.comProMIS stock rockets 115% amid preclinical data for Alzheimer's drugJuly 17, 2023 | msn.comProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineJuly 17, 2023 | finance.yahoo.comProMIS Announces Completion of ContinuanceJuly 14, 2023 | finance.yahoo.comProMIS Neurosciences Inc.: ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeJuly 10, 2023 | finanznachrichten.deProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeJuly 10, 2023 | finance.yahoo.comProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedJune 30, 2023 | finance.yahoo.comCORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeJune 29, 2023 | finance.yahoo.comProMIS Neurosciences Inc.: ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsMay 16, 2023 | finanznachrichten.deProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseMay 8, 2023 | finance.yahoo.comClosing Bell: Promis Neurosciences Inc up on Wednesday (PMN)April 27, 2023 | theglobeandmail.comClosing Bell: Promis Neurosciences Inc down on Wednesday (PMN)April 19, 2023 | theglobeandmail.comProMIS Neurosciences submits IND application for Alzheimer's treatmentApril 10, 2023 | proactiveinvestors.comProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310April 10, 2023 | finance.yahoo.comLead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023March 29, 2023 | finance.yahoo.comProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023March 13, 2023 | finance.yahoo.comProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingMarch 13, 2023 | finance.yahoo.comPMN.TO - | Stock Price & Latest News | ReutersJanuary 22, 2023 | reuters.comPMN:CA ProMIS Neurosciences, Inc.October 26, 2022 | seekingalpha.comProMIS Neurosciences, Inc. (PMN)October 17, 2022 | finance.yahoo.comCan ProMIS Neurosciences (TSE:PMN) Afford To Invest In Growth?August 15, 2022 | finance.yahoo.comProMIS Neurosciences Presents at 2022 Alzheimer's Association International ConferenceAugust 4, 2022 | financialpost.comProMIS Neurosciences Presents at 2022 Alzheimer’s Association International ConferenceAugust 2, 2022 | finance.yahoo.comProMIS Neurosciences to Present at 2022 Alzheimer’s Association International ConferenceJuly 27, 2022 | finance.yahoo.comProMIS Neurosciences Rings the Closing BellJuly 15, 2022 | nasdaq.comProMIS at 52-Week HighJuly 1, 2022 | ca.finance.yahoo.com Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address PMN Media Mentions By Week PMN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMN News Sentiment▼0.000.61▲Average Medical News Sentiment PMN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMN Articles This Week▼00▲PMN Articles Average Week Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fennec Pharmaceuticals News Today Medicenna Therapeutics News Today Oncolytics Biotech News Today Covalon Technologies News Today Theratechnologies News Today Microbix Biosystems News Today Sernova News Today Hemostemix News Today Aeterna Zentaris News Today Sirona Biochem News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:PMN) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
